AN OVERVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH
Harika Javangula
Abstract
Harika Javangula
Abstract
Application of economic evaluations to the pharmaceuticals is termed as Pharmacoeconomics. There is a prolonged significance in the assessment of economic efficiency of health care programmes which is accomplished through economic evaluation where the costs, benefits and consequences of alternative new drugs, therapies and treatments are compared and contrasted. Various fundamental forms of evaluations such as COL, CBA, CMA, CEA etc are widely used and thereby estimates whether the enhanced significance in economic analysis is promising to the patients, clinicians and the society. Outcomes research deals with the identification, measurement and evaluation of the result of health care researches in general.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Application of economic evaluations to the pharmaceuticals is termed as Pharmacoeconomics. There is a prolonged significance in the assessment of economic efficiency of health care programmes which is accomplished through economic evaluation where the costs, benefits and consequences of alternative new drugs, therapies and treatments are compared and contrasted. Various fundamental forms of evaluations such as COL, CBA, CMA, CEA etc are widely used and thereby estimates whether the enhanced significance in economic analysis is promising to the patients, clinicians and the society. Outcomes research deals with the identification, measurement and evaluation of the result of health care researches in general.
Key concepts: Pharmacoeconomics, Economic evaluation, Outcomes research, Identification (biology), Health care, Health economics, Cost–benefit analysis, Medicine